Abstract

BackgroundNucleotide-actived P2Y receptors play critical roles in the growth of tumor cells by regulating cellular proliferation, differentiation and survival.ResultsHere we demonstrate that an avian P2Y purinoceptor (tP2YR) with unique pharmacological and signal transduction properties induces morphologic and growth transformation of rodent fibroblasts. tP2YR induced a transformed phenotype similar to the mas oncogene, a G protein-coupled receptor which causes transformation by activation of Rac-dependent pathways. tP2YR-transformed cells exhibited increased steady-state activation of Rac1 and RhoA. Like activated Rho GTPases, tP2YR cooperated with activated Raf and caused synergistic transformation of NIH3T3 cells. Our data indicate that the ability of tP2YR to cause transformation is due to its unique ability among purinergic receptors to simultaneously activate Gαq and Gαi. Co-expression of constitutively activated mutants of these two Gα subunits caused the same transformed phenotype as tP2YR and Mas. Furthermore, transformation by both tP2YR and Mas was blocked by pharmacological inhibition of GαI by pertussis toxin (PTX) indicating an essential role for Gαi in transformation by these G-protein coupled receptors.ConclusionsOur data suggest that coordinated activation of Gαq and Gαi may link the tP2YR and possibility the Mas oncogene with signaling pathways resulting in activation of Rho family proteins to promote cellular transformation.

Highlights

  • Nucleotide-actived P2Y receptors play critical roles in the growth of tumor cells by regulating cellular proliferation, differentiation and survival

  • Extracellular nucleotides such as adenosine 5’-triphosphate (ATP), adenosine 5’-diphosphate (ADP), uridine 5’-diphosphate (UDP) and uridine 5’-triphosphate (UTP) interact with purinergic receptors to modulate a broad spectrum of physiological responses [1]

  • Depending on the combination of purinoceptors expressed in a tumor cell line and the second messenger pathways stimulated upon activation, addition or release of ATP could potentially promote or inhibit tumor growth [4,5,6]

Read more

Summary

Introduction

Nucleotide-actived P2Y receptors play critical roles in the growth of tumor cells by regulating cellular proliferation, differentiation and survival. Extracellular nucleotides such as adenosine 5’-triphosphate (ATP), adenosine 5’-diphosphate (ADP), uridine 5’-diphosphate (UDP) and uridine 5’-triphosphate (UTP) interact with purinergic receptors to modulate a broad spectrum of physiological responses [1]. Depending on the combination of purinoceptors expressed in a tumor cell line and the second messenger pathways stimulated upon activation, addition or release of ATP could potentially promote or inhibit tumor growth [4,5,6]. In addition to a role in the promotion of cellular proliferation, a mutated P2Y2 receptor has been isolated in an expression screen to identify potential transforming genes expressed in a colorectal cancer cell line [12]. The oncogenic potential of this mutated P2Y2 receptor was confirmed in focus formation, soft agar and tumorigenicity assays in nude mice

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call